Daily Headlines for December 14, 2015 NEW STATE LAWS

Dec 14, 2015

Today’s Top Story

CalChamber Board Votes to Oppose New Property Tax Initiative
The California Chamber of Commerce today announced that its Board of Directors has voted to oppose the Property Tax Surcharge to Fund Poverty Reduction Programs initiative.

??Public Affairs / Politics

Legislature Fizzles in Special Sessions on Transportation and Healthcare
Legislative committees convened in both special sessions have met only a handful of times since lawmakers decamped to their districts in late summer, and even then the hearings have mostly been information-only events and not ones designed to produce action. Los Angeles Times 

Drought Worries Weren’t Enough to Force Agreement on California Water
California lawmakers’ repeated failures to agree on legislation to resolve the state’s seemingly endless battle over how to use its water resources raise new questions about whether they’ll ever be able to find a compromise. The Sacramento Bee

Democrat Roger Hernández to Challenge Veteran Rep. Grace Napolitano
Assemblyman Roger Hernández of West Covina will announce Saturday that he is running for the 32nd Congressional District, pitting him against veteran Rep. Grace Flores Napolitano, a fellow Democrat who last week celebrated her 79th birthday. The Sacramento Bee

?Human Resources / Health & Safety

New State Laws Address Gender Pay Gap, Child Care, Disability Leave
About three dozen employment laws take effect in California next year, including ones that bolster equal-pay protections, help workers with chronic health conditions and give parents unpaid time off to research schools and deal with child care emergencies. San Francisco Chronicle

California Workers’ Comp Overhaul Cut Medical Costs
A 2012 legislative overhaul of compensation for work-related injuries and illnesses appears to have had the desired effect of reducing medical costs, two new independent studies say. The Sacramento Bee

Drug Approvals Top 2014 High But R&D Returns Still Struggle
The number of new drugs approved in the United States this year has already topped last year’s 18-year high, yet large pharmaceutical companies are still struggling to get a decent return on their research dollars. Reuters

Posted in Featured Articles.